Molecular Partners is a biopharmaceutical company that focuses on the discovery, development, and commercialization of biopharmaceutical products for the treatment of wet age-related macular degeneration and diabetic macular edema. It also develops ankyrin repeat protein therapies used in ophthalmology, oncology, inflammation, and other therapeutic treatments.